p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer (original) (raw)
References
Auer, G., Einhorn, N., Nilsson, B., Silfversward, C. & Sjovall, K. (1996). Biological malignancy grading in early-stage ovarian carcinoma. Acta Oncol8: 93–98. Article Google Scholar
Backe, J., Gassel, A. M., Hauber, K., Krebs, S., Bartek, J., Caffier, H., Kreipe, H-H, Muller-Hermelink, H-K & Dietl, J. (1997). p53 protein in endometrial cancer is related to proliferative activity and prognosis but not to expression of p21 protein. Int J Gynecol Pathol16: 361–368. ArticleCASPubMed Google Scholar
Barboule, N., Mazars, P., Baldin, V., Vidal, S., Jozan, S., Martel, P. & Valette, A. (1995). Expression of p21WAF1/CIP1 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma. Int J Cancer63: 611–615. ArticleCASPubMed Google Scholar
Boring, C. C., Squires, T. S., Tong, T. & Montgomery, S. (1994). Cancer statistics, 1994. CA Cancer J Clin44: 7–26. ArticleCASPubMed Google Scholar
Bukholm, I. K., Nesland, J. M., Karesen, R., Jacobsen, U. & Borresen, A. L. (1997). Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas. J Pathol181: 140–145. ArticleCASPubMed Google Scholar
Cancer Committee of the International Federation of Gynecology, Obstetrics (1989). Staging Announcement: FIGO Cancer Committee. Gynecol Oncol25: 383–385.
Cox, D. R. (1972). Regression models and life tables with discussion. J Stat Soc B34: 187–192. Google Scholar
Diab, S. G., Yu, Y., Hilsenbeck, S. G., Allred, D. C. & Elledge, R. M. (1997). WAF1/CIP1 protein expression in human breast tumors. Breast Cancer Res Treat43: 99–103. ArticleCASPubMed Google Scholar
Doglioni, C., Pelosio, P., Laurino, L., Macri, E., Meggiolaro, E., Favretti, F. & Barbareschi, M. (1996). p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation. J Pathol179: 248–253. ArticleCASPubMed Google Scholar
Elbendary, A., Berchuck, A., Davis, P., Havrilesky, I., Bast, R. C. Jr, Iglehart, J. D. & Marks, J. R. (1994). Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ5: 1301–1307. CASPubMed Google Scholar
Elbendary, A. A., Cirisano, F. D., Evans, A. C., Davis, P. L., Iglehart, J. D., Marks, J. R. & Berchuk, A. (1996). Relationship between p21 expression and mutation of p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. Clin Cancer Res2: 1571–1575. CASPubMed Google Scholar
El-Deiry, W. S., Harper, J. W., O’Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., Wang, Y., Wiman, K. G., Mercer, W. E., Kastan, M. B., Kohn, K. W., Elledge, S. J., Kinzler, K. W. & Vogelstein, B. (1994). WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res54: 1169–1174. CASPubMed Google Scholar
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. & Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell75: 817–825. ArticleCASPubMed Google Scholar
El-Deiry, W. S., Tokino, T., Waldman, T., Oliner, J. D., Velculescu, V. E., Burrell, M., Hill, D. E., Healy, E., Rees, J. L., Hamilton, S. R., Kinzler, K. W. & Vogelstein, B. (1995). Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res55: 2910–2919. CASPubMed Google Scholar
Engeland, A., Haldorsen, T., Tretli, S., Hakulinen, T., Horte, L. G., Luostarinen, T., Schou, G., Sigvaldason, H., Storm, H. H. & Tulinius, H. (1995). Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis: a collaborative study of five Nordic cancer registries. APMIS Suppl49: 81–83. Google Scholar
Finnish Cancer Registry (1997). Cancer incidence in Finland 1995. Cancer statistics of the National Research and Development Center for Welfare and Health. Cancer Society of Finland, No. 58
Garzetti, G. G., Ciavattini, A., Gotteri, G., De Nictolis, M., Stramazzotti, D., Lucarini, G. & Biagini, G. (1995). Ki 67 immunostaining (MIB1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance. Gynecol Oncol56: 169–174. ArticleCASPubMed Google Scholar
Gomyo, Y., Ikeda, M., Osaki, M., Tatebe, S., Tsujitani, S., Ikeguchi, M., Kaibara, N. & Ito, H. (1997). Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma. Cancer79: 2067–2072. ArticleCASPubMed Google Scholar
Harada, N., Gansauge, S., Gansauge, F., Gause, H., Shimoyama, S., Imaizumi, T., Mattfield, T., Schoenberger, M. H. & Beger, H. G. (1997). Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in pancreatic cancer. Br J Cancer76: 299–305. ArticleCASPubMedPubMed Central Google Scholar
Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell75: 805–816. ArticleCASPubMed Google Scholar
Henriksen, R., Strang, P., Wilander, E., Backstrom, T., Tribukait, B. & Oberg, K. (1994). p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry. Gynecol Oncol53: 301–306. ArticleCASPubMed Google Scholar
Herod, J. J., Eliopoulos, A. G., Warwick, J., Niedobitek, G., Young, L. S. & Kerr, D. J. (1996). The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. Cancer Res56: 2178–2184. CASPubMed Google Scholar
Ito, K., Sasano, H., Matsunaga, G., Sato, S., Yajima, A., Nasim, S. & Garret, C. (1997). Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma. J Pathol183: 318–324. ArticleCASPubMed Google Scholar
Ito, Y., Kobayashi, T., Takeda, T., Komoike, Y., Wakasugi, E., Tamaki, Y., Tsujimoto, M., Matsuura, N. & Monden, M. (1996). Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues. Br J Cancer74: 1269–1274. ArticleCASPubMedPubMed Central Google Scholar
Jiang, H., Lin, J., Su, Z. Z., Collart, F. R., Huberman, E. & Fisher, P. B. (1994). Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene9: 3397–3406. CASPubMed Google Scholar
Jiang, M., Shao, Z. M., Wu, J., Lu, J. S., Yu, L. M., Yuan, J. D., Han, Q. X., Shen, Z. Z. & Fontana, J. A. (1997). p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis. Int J Cancer74: 529–534. ArticleCASPubMed Google Scholar
Kaplan, E. L. & Meier, P. (1958). Nonparametric estimation from incomplete observations. J Am Stat Assoc53: 457–481. Article Google Scholar
Klemi, P. J., Pylkkänen, L., Kiilholma, P., Kurvinen, K. & Joensuu, H. (1995). p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma. Cancer76: 1201–1208. ArticleCASPubMed Google Scholar
Kohler, M. F., Kerns, B. J., Humphrey, P. A., Marks, J. R., Bast, R. C. Jr & Berchuck, A. (1993a). Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet Gynecol81: 643–650. CASPubMed Google Scholar
Kohler, M. F., Marks, J. R., Wiseman, R. W., Jacobs, I. J., Davidoff, A. M., Clarke Pearson, D. L., Soper, J. T., Bast, R. C. Jr & Berchuck, A. (1993b). Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J Natl Cancer Inst85: 1513–1519. ArticleCASPubMed Google Scholar
Kondo, S., Barna, B. P., Kondo, Y., Tanaka, Y., Casey, G., Liu, J., Morimura, T., Kaakaji, R., Peterson, J. W., Werbel, B. & Barrett, G. H. (1996). WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. Oncogene13: 1279–1285. CASPubMed Google Scholar
Levesque, M. A., Katsaros, D., Yu, H., Zola, P., Sismondi, P., Giardina, G. & Diamandis, E. P. (1995). Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma. Cancer75: 1327–1338. ArticleCASPubMed Google Scholar
Lukas, J., Groshen, S., Saffari, B., Niu, N., Reles, A., Wen, W. H., Felix, J., Jones, L. A., Hall, F. L. & Press, M. F. (1997). WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Am J Pathol150: 167–175. CASPubMedPubMed Central Google Scholar
Marchetti, A., Doglioni, C., Barbareschi, M., Buttita, F., Pellegrini, S., Bertacca, G., Chella, A., Merlo, G., Angeletti, C. A., Palma, P. D. & Bevilacqua, G. (1996). p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene12: 1319–1324. CASPubMed Google Scholar
Marks, J. R., Davidoff, A. M., Kerns, B. J., Humphrey, P. A., Pence, J. C., Dodge, R. K., Clarke Pearson, D. L., Iglehart, J. D., Bast, R. C. Jr & Berchuck, A. (1991). Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res51: 2979–2984. CASPubMed Google Scholar
Mateo, M. S., Saez, A. L., Sanchez-Beato, M., Garcia, P., Sanchez-Verde, L., Martinez, J. C., Orradre, J. L. & Piris, M. A. (1997). Expression of p21WAF1/CIP1 in fetal and adult tissues: simultaneous analysis with Ki67 and p53. J Clin Pathol50: 645–653. ArticleCASPubMedPubMed Central Google Scholar
Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E. & Givol, D. (1994). Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res54: 3391–3395. CASPubMed Google Scholar
Ogawa, M., Maeda, K., Onoda, N., Chung, Y. S. & Sowa, M. (1997). Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma. Br J Cancer75: 1617–1620. ArticleCASPubMedPubMed Central Google Scholar
Palazzo, J. P., Mercer, W. E., Kovatich, A. J. & McHugh, M. (1997). Immunohistochemical localization of p21WAF1/CIP1 in normal, hyperplastic, and neoplastic uterine tissues. Hum Pathol28: 60–66. ArticleCASPubMed Google Scholar
Parker, S. L., Tong, T., Bolden, S. & Wingo, P. A. (1997). Cancer statistics, 1997. CA Cancer J Clin47: 5–27. ArticleCASPubMed Google Scholar
Serov, S. F., Scully, R. & Sobin, L. H. (1973). Histological typing of ovarian tumours. International Histological Classification of Tumors, no 9: Geneva: WHO Google Scholar
Sheikh, M. S., Li, X. S., Chen, J. C., Shao, Z. M., Ordonez, J. V. & Fontana, J. A. (1994). Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene9: 3407–3415. CASPubMed Google Scholar
Shigemasa, K., Hu, C., West, C. M., Moon, S. H., Parham, G. P., Parmley, T. H., Korourian, S., Baker, V. V. & O’Brien, T. J. (1997). p21: a monitor of p53 dysfunction in ovarian neoplasia. Int J Gynecol Cancer7: 296–303. Article Google Scholar
Wakasugi, E., Kobayashi, T., Tamaki, Y., Ito, Y., Miyashiro, I., Komoike, Y., Takeda, T., Shin, E., Takatsuka, Y., Kikkawa, N., Monden, T. & Monden, M. (1997). p21 (Waf1/Cip1) and p53 protein expression in breast cancer. Am J Clin Pathol107: 684–691. ArticleCASPubMed Google Scholar
van der Zee, A. G., Hollema, H., Suurmeijer, A. J., Krans, M., Sluiter, W. J., Willemse, P. H., Aalders, J. G. & de Vries, E. G. (1995). Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas. J Clin Oncol13: 70–78. ArticleCASPubMed Google Scholar
Wan, M., Zweizig, S., D’Ablaing, G., Zheng, J., Velicescu, M. & Dubeau, L. (1994). Three distinct regions of chromosome 6 are targets of loss of heterozygosity in human ovarian carcinomas. Int J Oncol5: 1043–1048. CASPubMed Google Scholar
Werness, B. A., Jobe, J. S., DiCioccio, R. A. & Piver, M. S. (1997a). Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohistochemistry. Int J Gyn Pathol16: 149–155. ArticleCAS Google Scholar
Werness, B. A., Wang, H-Q, Chance, J. & Goldstein, D. J. (1997b). p53-independent expression of p21waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix. Mod Pathol10: 578–584. CASPubMed Google Scholar
Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A. B. & Mercer, W. E. (1995). p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res55: 668–674. CASPubMed Google Scholar